Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

首页> 外文期刊>Journal of international management >Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

【24h】

Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

机译：两种炎症肠病患者每3周治疗Ustekinumab 90毫克

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of international management》 |2020年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类管理学;
关键词

相似文献

外文文献
中文文献
专利

1. Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks [J] . Journal of international management . 2020,第2期

机译：两种炎症肠病患者每3周治疗Ustekinumab 90毫克
2. Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis [J] . Novello Matteo, Stocchi Luca, Holubar Stefan, International journal of colorectal disease. . 2019,第3期

机译：用Ustekinumab对炎症性肠病患者治疗的患者的手术结果：匹配案例分析
3. SURGICAL OUTCOMES OF PATIENTS TREATED WITH USTEKINUMAB VS. VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE. [J] . Novello M., Holubar S., Shawki S., Diseases of the Colon and Rectum . 2018,第5期

机译：用Ustekinumab对待患者的外科结果与 Vedolizumab在炎症性肠病中。
4. HIGHLIGHTS FROM DIGESTIVE DISEASES WEEK WITH VETERINARY CORRELATES: INFLAMMATORY BOWEL DISEASE [C] . Karin Allenspach American College of Veterinary Internal Medicine Forum . 2010

机译：来自兽医的消化疾病周的亮点：炎症性肠病
5. The Effect of Bowel Preparations on the Bacterial Flora of the Colon in Healthy Subjects and in Patients with Inflammatory Bowel Disease [D] . Shobar, Rima M. 2012

机译：肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
6. A90 THREE PATIENTS WITH INFLAMMATORY BOWEL DISEASE DIAGNOSED WHILE BEING TREATED WITH SECUKINUMAB FOR PSORIASIS [O] . T Shukla, J McCurdy, S Fahim, 2018

机译：A90经SECUKINUMAB治疗的确诊为炎症性肠病的三例患者
7. Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks [O] . Thomas Chateau, Laurent Peyrin-Biroulet 2019

机译：两种炎症肠病患者每3周治疗Ustekinumab 90毫克

Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

著录项

相似文献

相关主题

期刊订阅